Bag-1 and Bcl-2 gene transfer in malignant glioma: Modulation of cell cycle regulation and apoptosis

Brain Pathology

Volumn 10, Issue 2, 2000, Pages 223-234

  Roth, Wilfried ^a   Grimmer, Cornelia ^a   Rieger, Lorenz ^a   Strik, Herwig ^b   Takayama, Shinichi ^c   Krajewski, Stanislaw ^c   Meyermann, Richard ^b   Dichgans, Johannes ^a   Reed, John C ^c   Weller, Michael ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CAMPTOTHECIN; CISPLATIN; CYCLOHEXIMIDE; CYTARABINE; FAS ANTIGEN; HEAT SHOCK PROTEIN; NIMUSTINE; PROTEIN BCL 2; STAUROSPORINE; TENIPOSIDE; VINCRISTINE;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER SURVIVAL; CELL CYCLE; CELL GROWTH; CELL PROLIFERATION; CELL PROTECTION; CELL SURVIVAL; CLONOGENESIS; GENE EXPRESSION; GENE TRANSFER; GLIOMA; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MOUSE; NONHUMAN; NUDE MOUSE; PROTEIN EXPRESSION; REGULATORY MECHANISM; TRANSGENE; TUMOR XENOGRAFT;

EID: 18844481705     PISSN: 10156305     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2000.tb00256.x     Document Type: Article

References (33)

1. Huang DC, O'Reilly LA, Strasser A, Cory S (1997) The anti-apoptosis function of Bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry. EMBO J 16:4628-4638
2. Kitada S, Andersen J, Akar S, Zapata JM, Takayama S, Krajewski S, Wang HG, Zhang X, Bullrich F, Croce CM, Rai K, Mines J, Reed JC (1998) Expression of apoptosisregulating proteins in chronic lymphocytic leukemia: correlations with in vitro and in vivo chemoresponses. Blood 91: 3379-3389
3. Knowlton K, Mancini M, Creason S, Morales C, Hockenbery D, Anderson BO (1998) Bcl-2 slows in vitro breast cancer growth despite its antiapoptotic effect. J Surg Res 76: 22-26
4. Krajewski S, Krajewska M, Ehrmann J, Sikorska M, Lach B, Chatten J, Reed JC (1997) Immunohistochemical analysis of Bcl-2, Bcl-X, Mcl-1, and Bax in tumors of central and peripheral nervous system origin. Am J Pathol 150:805-814
5. Liu R, Takayama S, Zheng Y, Froesch B, Chen GQ, Zhang X, Reed JC, Zhang XK (1998) Interaction of Bag-1 with retinoic acid receptor and its inhibition of retinoic acid-induced apoptosis in cancer cells. J Biol Chem 273: 16985-16992
6. Matsuzawa S, Takayama S, Froesch BA, Zapata JM, Reed JC (1998) p53-inducible human homologue of Drosophila seven in absentia (Siah) inhibits cell growth: suppression by Bag-1. EMBO J 17: 2736-2747
7. Naumann U, Weller M. (1998) Retroviral BAX gene transfer fails to sensitize malignant glioma cells to CD95L-induced apoptosis and cancer chemotherapy. Int J Cancer 77: 645-648
8. Newcomb EW, Bhalla SK, Parrish CL, Hayes RL, Cohen H, Miller DC (1997) bcl-2 protein expression in astrocytomas in relation to patient survival and p53 gene status. Acta Neuropathol Berl 94: 369-375
9. Newcomb EW, Cohen H, Lee SR, Bhalla SK, Bloom J, Hayes RL, Miller DC (1998) Survival of patients with glioblastoma multiforme is not influenced by altered expression of p16, p53, EGFR, MDM2 or Bcl-2 genes. Brain Pathol 8: 655-667
10. Reed JC (1997) Double identity for proteins of the Bcl-2 family. Nature 387: 773-776
11. Rieger L, Weller M, Bornemann A, Schabet M, Dichgans J, Meyermann R (1998) Bcl-2 family protein expression in human malignant glioma: a clinical-pathological correlative study. J Neurol Sci 155: 68-75
12. Roth W, Fontana A, Trepel M, Reed JC, Dichgans J, Weller M (1997) Immunochemotherapy of malignant glioma: synergistic activity of CD95 ligand and chemotherapeutics. Cancer Immunol Immunother 44: 55-63
13. Roth W, Isenmann S, Naumann U, Kügler S, Bähr M, Dichgans J, Ashkenazi A, Weller M (1999) Locoregional Apo2L/TRAIL eradicates intracranial human malignant glioma xenografts in athymic mice in the absence of neurotoxicity. Biochem Biophys Res Commun 265: 479-483
14. Roth W, Wagenknecht B, Dichgans J, Weller M (1998) Interferon-a enhances CD95L-induced apoptosis of human malignant glioma cells. J Neuroimmunol 87: 121-129
15. Roth W, Wagenknecht B, Grimmel C, Dichgans J, Weller M (1998) Taxol-mediated augmentation of CD95 ligand-induced apoptosis of human malignant glioma cells: association with bcl-2 phosphorylation but neither activation of p53 nor G2/M cell cycle arrest. Br J Cancer 77: 404-411
16. Roth W, Weller M (1999) Chemotherapy and immunotherapy of malignant glioma: molecular mechanisms and clinical perspectives. Cell Mol Life Sci 56: 481-506
17. Schulz JB, Bremen D, Reed JC, Lommatzsch J, Takayama S, Wüllner U, Löschmann PA, Klockgether T, Weller M (1997) Cooperative interception of neuronal apoptosis by Bcl-2 and Bag-1 expression: prevention of caspase activation and reduced production of reactive oxygen species. J Neurochem 69: 2075-2086
18. Strik H, Deininger M, Streffer J, Grote E, Wickboldt J, Dichgans J, Weller M, Meyermann R (1999) Bcl-2 family protein expression in initial and recurrent glioblastomas: modulation by radiochemotherapy. J Neurol Neurosurg Psych 67: 763-768
19. Takayama S, Sato T, Krajewski S, Kochel K, Irie S, Millan JA, Reed JC (1995) Cloning and functional analysis of Bag-1: a novel Bcl-2-binding protein with anti-cell death activity. Cell 80: 279-284
20. Takayama S, Kochel K, Irie S, Inazawa J, Abe T, Sato T, Druck T, Huebner K, Reed JC (1996) Cloning of cDNAs encoding the human Bag1 protein and localization of the human Bag1 gene to chromosome 9p12. Genomics 35: 494-498
21. Takayama S, Bimston DN, Matsuzawa S, Freeman BC, Aime Sempe C, Xie Z, Morimoto RI, Reed JC (1997) Bag-1 modulates the chaperone activity of Hsp70/Hsc70. EMBO J 16: 4887-4896
22. Takayama S, Krajewski S, Krajewska M, Kitada S, Zapata JM, Kochel K, Knee D, Scudiero D, Tudor G, Miller GJ, Miyashita T, Yamada M, Reed JC (1998) Expression and location of Hsp70/Hsc-binding anti-apoptotic protein BAG-1 and its variants in normal tissues and tumor cell lines. Cancer Res 58: 3116-3131
23. Tang SC, Shaheta N, Chernenko G, Khalifa M, Wang XK (1999) Expression of BAG-1 in invasive breast carcinomas. J Clin Oncol 17: 1710-1719
24. Terada S, Fukuoka K, Fujita T, Komatsu T, Takayama S, Reed JC, Suzuki E (1997) Anti-apoptotic genes, bag-1 and bcl-2, enabled hybridoma cells to survive under treatment for arresting cell cycle. Cytotechnol 25: 17-23
25. Trepel M, Groscurth P, Malipiero U, Gulbins E, Dichgans J, Weller M (1998) Chemosensitivity of human malignant glioma: modulation by p53 gene transfer. J Neuro-Oncol 39: 19-32
26. Vairo G, Innes KM, Adams JM (1996) Bcl-2 has a cell cycle inhibitory function separable from its enhancement of cell survival. Oncogene 13: 1511-1519
27. Van Meir EG, Kikuchi T, Tada M, Li H, Diserens AC, Wojcik BE, Huang HJ, Friedmann T, de TN, Cavenee WK (1994) Analysis of the p53 gene and its expression in human glioblastoma cells. Cancer Res 54: 649-652
28. Wagenknecht B, Schulz JB, Gulbins E, Weller M (1998) Crm-A, bcl-2 and NDGA inhibit CD95L-induced apoptosis of malignant glioma cells at the level of caspase 8 processing. Cell Death Differ 5: 894-900
29. Weller M, Frei K, Groscurth P, Krammer PH, Yonekawa Y, Fontana A (1994) Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines. J Clin Invest 94: 954-964
30. Weller M, Malipiero U, Aguzzi A, Reed JC, Fontana A (1995) Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation. J Clin Invest 95: 2633-2643
31. Weller M, Rieger J, Grimmel C, Van Meir EG, De Tribolet N, Krajewski S, Reed JC, von Deimling A, Dichgans J (1998) Predicting chemoresistance in human malignant glioma cells: the role of molecular genetic analyses. Int J Cancer 79: 640-644
32. Wick W, Wagner S, Kerkau S, Dichgans J, Tonn JC, Weller M (1998) BCL-2 promotes migration and invasiveness of human glioma cells. FEBS Lett 440: 419-424
33. Zapata JM, Krajewska M, Krajewski S, Huang RP, Takayama S, Wang HG, Adamson E, Reed JC (1998) Expression of multiple apoptosis-regulatory genes in human breast cancer cell lines and primary tumors. Breast Cancer Res Treat 47:129-140